| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Effects of intensive glucose lowering in type 2 diabetes.
|
N Engl J Med
|
2008
|
47.90
|
|
2
|
Effects of intensive blood-pressure control in type 2 diabetes mellitus.
|
N Engl J Med
|
2010
|
21.49
|
|
3
|
Effects of combination lipid therapy in type 2 diabetes mellitus.
|
N Engl J Med
|
2010
|
16.40
|
|
4
|
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.
|
Am J Cardiol
|
2007
|
9.62
|
|
5
|
Feasibility of treating prehypertension with an angiotensin-receptor blocker.
|
N Engl J Med
|
2006
|
9.40
|
|
6
|
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
|
Lancet
|
2010
|
9.20
|
|
7
|
Long-term effects of intensive glucose lowering on cardiovascular outcomes.
|
N Engl J Med
|
2011
|
8.14
|
|
8
|
Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
|
J Clin Hypertens (Greenwich)
|
2002
|
6.03
|
|
9
|
Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.
|
Arch Intern Med
|
2005
|
4.24
|
|
10
|
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
|
JAMA
|
2003
|
3.71
|
|
11
|
Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
|
J Am Soc Nephrol
|
2006
|
3.51
|
|
12
|
Spinal manipulation, medication, or home exercise with advice for acute and subacute neck pain: a randomized trial.
|
Ann Intern Med
|
2012
|
3.16
|
|
13
|
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
|
Am J Cardiol
|
2007
|
3.10
|
|
14
|
Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement.
|
Hypertension
|
2010
|
2.47
|
|
15
|
Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial.
|
Hypertension
|
2008
|
2.44
|
|
16
|
Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
|
Diabetes Care
|
2010
|
2.42
|
|
17
|
Supervised exercise, spinal manipulation, and home exercise for chronic low back pain: a randomized clinical trial.
|
Spine J
|
2011
|
1.74
|
|
18
|
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
|
Hypertension
|
2006
|
1.73
|
|
19
|
Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR.
|
Clin J Am Soc Nephrol
|
2012
|
1.62
|
|
20
|
Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial.
|
Hypertension
|
2011
|
1.46
|
|
21
|
The effects of amlodipine compared to losartan in patients with mild to moderately severe hypertension.
|
J Clin Hypertens (Greenwich)
|
2003
|
1.44
|
|
22
|
Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium.
|
Am J Hypertens
|
2010
|
1.07
|
|
23
|
Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
|
J Clin Hypertens (Greenwich)
|
2011
|
1.04
|
|
24
|
New salt-sensitivity metrics: variability-adjusted blood pressure change and the urinary sodium-to-creatinine ratio.
|
Ethn Dis
|
2002
|
0.95
|
|
25
|
Treatment of Hypertension with Alternative Therapies (THAT) Study: a randomized clinical trial.
|
J Hypertens
|
2002
|
0.86
|
|
26
|
Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region.
|
J Hypertens
|
2005
|
0.80
|
|
27
|
How acceptable are financial incentives and written feedback for improving hypertension control? Perspectives from physicians, clinic administrators, and patients.
|
Am J Manag Care
|
2002
|
0.78
|
|
28
|
Self-reported hypertension treatment beliefs and practices of primary care physicians in a managed care organization.
|
Am J Hypertens
|
2005
|
0.78
|
|
29
|
Using diuretics in practice--one opinion.
|
J Clin Hypertens (Greenwich)
|
2008
|
0.78
|
|
30
|
Risk of hospitalized gastrointestinal bleeding in persons randomized to diuretic, ACE-inhibitor, or calcium-channel blocker in ALLHAT.
|
J Clin Hypertens (Greenwich)
|
2013
|
0.75
|
|
31
|
Recommendations and guidelines regarding the preferred research protocol for investigating the impact of an optimal healing environment on patients with hypertension.
|
J Altern Complement Med
|
2004
|
0.75
|